ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Archives of Disease in Childhood 2007;92:831
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauchner, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bauchner, H.
Topic Collections
Right arrowRelevant Articles

Atoms

Howard Bauchner, Editor-in-Chief

The first 150 words of the full text of this article appear below.


A CLINICAL RESEARCH NETWORK FOR CHILDREN
Randomised clinical trials are the cornerstone of evidence based medicine and the Cochrane Collaboration. They influence the statements of important professional groups like National Institute for Health and Clinical Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN). Professor Ros Smyth, in her leading article, details the development and organisation of the Medicines for Children Research Network (MCRN). The coordinating centre is based in Liverpool, but there are also six regional local research networks. The centre helps coordinate multi-site clinical trials. Numerous clinical studies groups have been established—they are responsible for the development of the MCRN’s research portfolio. The need for the MCRN is highlighted by a short report from the Brompton. They found in a small number of children with cystic fibrosis, cared for at a single-centre, that 8 of 18 children without respiratory systems were positive for bacteria on bronchoalveolar lavage. Should all children with cystic fibrosis, regardless of . . . [Full text of this article]


Relevant Articles

Making a difference: the clinical research programme for children
Rosalind L Smyth
Arch. Dis. Child. 2007 92: 835-837. [Extract] [Full Text] [PDF]

Is there an intrauterine influence on obesity? Evidence from parent–child associations in the Avon Longitudinal Study of Parents and Children (ALSPAC)
George Davey Smith, Colin Steer, Sam Leary, and Andy Ness
Arch. Dis. Child. 2007 92: 876-880. [Abstract] [Full Text] [PDF]

Infant feeding in the second 6 months of life related to iron status: an observational study
David Hopkins, Pauline Emmett, Colin Steer, Imogen Rogers, Sian Noble, and Alan Emond
Arch. Dis. Child. 2007 92: 850-854. [Abstract] [Full Text] [PDF]

Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative Study
Nikki J Blair, John M D Thompson, Peter N Black, David M O Becroft, Phillipa M Clark, Dug Yeo Han, Elizabeth Robinson, Karen E Waldie, Chris J Wild, and Edwin A Mitchell
Arch. Dis. Child. 2007 92: 866-871. [Abstract] [Full Text] [PDF]

Ethnic and gender differences in body fat in British schoolchildren as measured by DXA
Nicholas J Shaw, Nicola J Crabtree, Mohammed S Kibirige, and John N Fordham
Arch. Dis. Child. 2007 92: 872-875. [Abstract] [Full Text] [PDF]

Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline?
Simon Cohen, Jonny Taitz, and Adam Jaffé
Arch. Dis. Child. 2007 92: 847-849. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health